ArticleChemistry & biodiversity2026
Antioxidant and Antihypertensive Activities of Ficus exasperata Vahl Leaves: Integrated In Vitro Evaluation and In Silico Multi-Target Mechanistic Insights.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension (HTN) remains a major global health challenge and a leading cause of cardiovascular morbidity. The limitations of conventional antihypertensive therapies, including high cost and side effects, highlight the need for alternative interventions. This study evaluated the antioxidant and antihypertensive properties of F. exasperata leaf Vahl extracts using in vitro and in silico approaches. Aqueous (AE) and ethanol (EE) extracts were analyzed for total phenolic and flavonoid contents. Antioxidant activity was assessed by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assays, while angiotensin-converting enzyme (ACE) inhibitory activity was compared with captopril. Gas chromatography-mass spectrometry (GC-MS) analysis identified phytochemical constituents. Network pharmacology and molecular docking targeted oxidative stress-induced hypertension-related targets, and molecular dynamics simulations evaluated ligand-protein stability. EE showed higher flavonoid content (274.09 mg QE/g) and stronger antioxidant activity (DPPH IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.